Our Resources

The increased adoption of digital health technologies will be an enduring positive legacy of the pandemic. Telehealth immediately springs to mind, but the increased and more sophisticated use of remote patient monitoring is another encouraging evolution, with the potential to radically improve the clinical trial experience. Here are five key things to keep in mind when planning for RPM in your next DCT.

Low Risk, High Reward: Harnessing A Hybrid Approach to Pharmaceutical Clinical Trials

Digital transformation is reshaping nearly every industry, and clinical trials are no exception. As technology plays a bigger role in healthcare, patients are demanding more access to medical research. It’s not just patients who are asking for more: Medical professionals, researchers, and pharmaceutical companies all want to improve quality, efficiency, and access to clinical trials.

ObvioHealth was asked to recruit and manage a study to assess the effectiveness of ‘growing up’ milk formulas in supporting the health, growth, and development of children.

ObvioHealth was asked to conduct an observational study of infant crying and fussing.

Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).

The use of real world data in clinical trials is a hot topic. Doctors, biotech and pharmaceutical companies alike point to the tremendous potential to leverage this data to improve health outcomes.

A global consumer packaged goods company wanted to understand the effectiveness of an herbal blend on menopause symptoms and quality of life (QoL).